• Follow
  • Follow
  • Follow
  • Follow
U

Search



Shop

w

News

w

Blog

DONATE
Team Jack Foundation
  • About Us
    • Our Mission
    • Jack Hoffman
    • Board & Staff
    • Financials
  • Our Impact
    • Scientific Advisory Board
    • Sponsored Grants
    • Research Articles
  • Brain Cancer
    • What is Brain Cancer?
      • What is DIPG?
    • Brain Cancer Facts
    • Cancer Awareness Months
      • Brain Tumor Awareness Month
    • Family Resources
  • Events
  • Get Involved
    • Fundraise
      • Host an Event
      • Run For Team Jack
      • Birthday Fundraiser
    • Give
    • Our Sponsors
    • Volunteer
  • Heroes
  • Donate
  • Shop
  • Blog
  • News
Select Page

Get Involved

Clinical Trial Finder

Search Results

Whack-a-Mole: Testing an Intervention to Increase Melanoma Identification

Study Purpose

The purpose of this study is to evaluate an interactive game designed to increase people's ability to identify cancerous moles.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Yes
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Resident of U.
S.
  • - At least 18 years old.
  • - Capable of reading English.
  • - Member of panel assembled by survey provider.

Exclusion Criteria:

- Individuals under 18 years old

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT04069104
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

University of Miami
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Nicholas Carcioppolo, PhDSoyoon Kim, PhD
Principal Investigator Affiliation Study Co-Principal InvestigatorStudy Co-Principal Investigator
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other
Overall Status Recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Diagnoses Disease
Arms & Interventions

Arms

: ABCD training with standard feedback

Asymmetry, Border, Color, Diameter (ABCD) training message intervention with standard dermatological feedback

: ABCD training with motivational feedback

ABCD training message intervention with dermatological feedback and a motivational message

: ABCD training with no feedback

ABCD message intervention with no feedback

: UDS method training with standard feedback

Ugly Duckling Sign (UDS) method message intervention with dermatological feedback.

: UDS method training with motivational feedback

UDS message intervention with dermatological feedback and a motivational message.

: UDS training with no feedback

UDS message intervention with no feedback.

: ABCD and UDS trainings with standard feedback

Both message interventions with dermatological feedback.

: ABCD and UDS trainings with motivational feedback

Both message interventions with dermatological feedback and a motivational message.

: ABCD and UDS trainings with no feedback

Both message interventions with no feedback.

: No message intervention with standard feedback

No message intervention, but with dermatological feedback.

: No message intervention with motivational feedback

No message intervention, but with dermatological feedback and a motivational message.

: No message intervention with no feedback

No message intervention and no feedback. True control.

Interventions

Behavioral: - ABCD Information

The intervention condition includes exposure to a message emphasizing the ABCD strategy to identify malignant melanoma.

Behavioral: - UDS information

The intervention condition includes exposure to a message emphasizing the UDS strategy to identify malignant melanoma.

Behavioral: - Standard (clinical) feedback

Feedback on mole identification task provided by a dermatologist.

Behavioral: - Motivational feedback

Feedback on mole identification task provided by a dermatologist plus exposure to a motivational fear appeal message designed to increase skin self exam intentions.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

University of Miami, Coral Gables, Florida

Status

Recruiting

Address

University of Miami

Coral Gables, Florida, 33146

Site Contact

Nicholas Carcioppolo, PhD

[email protected]

305-284-5633

Nearest Location

Site Contact

Nicholas Carcioppolo, PhD

[email protected]

305-284-5633


Resources

  • Patient and Caregiver Survey
  • Clinical Trial Endpoints
  • Research Resources
Powered By

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.

Make an impact through your inbox

News, upcoming events and research updates delivered straight to your inbox.

  • This field is for validation purposes and should be left unchanged.
MAKE AN IMPACT

Donate today to help the Team Jack Foundation fund research and fight pediatric brain cancer.

Make a Donation
  • About Us
  • Our Mission
  • Jack Hoffman
  • Board & Staff
  • Fund Allocation
  • Financials
  • Our Impact
  • Scientific Advisory Board
  • Sponsored Grants
  • Research Articles
  • Brain Cancer
  • Family Resources
  • Get Involved
  • Fundraise
  • Give
  • Events
  • Our Sponsors
  • Volunteer
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
seal of transparency badge - 2019 Gold
combined health agencies drive member charity badge
Share Omaha member badge
© 2021 Team Jack Foundation. PO Box 607, Atkinson, NE, 68713. All Rights Reserved. Team Jack Foundation, Inc. is exempt from federal income tax under section 501(c)3, ID Number 46-2301134, of the internal revenue code. All contributions to the Foundation are tax deductible. Privacy Policy • Contact